- Company Overview for STIEFEL LABORATORIES (U.K.) LTD (00831160)
- Filing history for STIEFEL LABORATORIES (U.K.) LTD (00831160)
- People for STIEFEL LABORATORIES (U.K.) LTD (00831160)
- More for STIEFEL LABORATORIES (U.K.) LTD (00831160)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
21 Oct 2024 | CS01 | Confirmation statement made on 20 October 2024 with no updates | |
23 Sep 2024 | AA | Audit exemption subsidiary accounts made up to 31 December 2023 | |
23 Sep 2024 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/23 | |
17 Sep 2024 | CH01 | Director's details changed for Mrs Laura Guittard on 11 September 2024 | |
11 Sep 2024 | PSC05 | Change of details for Setfirst Limited as a person with significant control on 11 September 2024 | |
11 Sep 2024 | PSC05 | Change of details for Glaxosmithkline Finance Plc as a person with significant control on 11 September 2024 | |
11 Sep 2024 | AD01 | Registered office address changed from 980 Great West Road Brentford Middlesex TW8 9GS England to 79 New Oxford Street London WC1A 1DG on 11 September 2024 | |
18 Jul 2024 | AD02 | Register inspection address has been changed to 79 New Oxford Street London WC1A 1DG | |
22 May 2024 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/23 | |
22 May 2024 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/23 | |
25 Oct 2023 | CS01 | Confirmation statement made on 20 October 2023 with updates | |
21 Aug 2023 | AA | Audit exemption subsidiary accounts made up to 31 December 2022 | |
21 Aug 2023 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/22 | |
21 Aug 2023 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/22 | |
21 Aug 2023 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/22 | |
16 Aug 2023 | CH02 | Director's details changed for Glaxo Group Limited on 6 June 2023 | |
20 Oct 2022 | CS01 | Confirmation statement made on 20 October 2022 with no updates | |
01 Oct 2022 | AA | Audit exemption subsidiary accounts made up to 31 December 2021 | |
18 Jul 2022 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/21 | |
18 Jul 2022 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/21 | |
18 Jul 2022 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/21 | |
18 Jul 2022 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/21 | |
31 Mar 2022 | AP01 | Appointment of Mrs Laura Guittard as a director on 11 January 2022 | |
31 Mar 2022 | TM01 | Termination of appointment of Ciara Martha Lynch as a director on 11 January 2022 | |
25 Jan 2022 | CS01 | Confirmation statement made on 19 January 2022 with no updates |